Press release
Insomnia Market to Expand Significantly by 2034, States DelveInsight Report
DelveInsight's "Insomnia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Insomnia, historical and forecasted epidemiology as well as the Insomnia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Insomnia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Insomnia Market Forecast
https://www.delveinsight.com/sample-request/insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Insomnia Market Report:
• The Insomnia market size was valued approximately ~USD 5,839 Million in 2023 and is anticipated to grow with a significant CAGR of 3.9% during the study period (2020-2034)
• The Insomnia market in the United States was valued at approximately USD 4,734 million in 2023 and is projected to grow at a notable CAGR of 4.1% over the forecast period.
• In 2023, the Insomnia market in the EU4 and the UK was valued at around USD 774 million and is expected to grow at a CAGR of 3.1%.
• Among the EU countries, France recorded the largest Insomnia market size at approximately USD 352 million in 2023, whereas Spain reported the smallest market size at around USD 82 million in the same year.
• The anticipated introduction of emerging therapies like Seltorexant (JNJ-42847922) and TS-142, among others, is expected to significantly influence the overall Insomnia market size in the coming years.
• In 2023, the United States recorded around 58,617 thousand diagnosed prevalent cases of Insomnia, a number expected to rise over the forecast period.
• In 2023, France accounted for a substantial portion of diagnosed prevalent insomnia cases among the EU4 and the UK, representing 43% of the total, whereas Spain had the lowest prevalence at only 11%. This difference underscores France's dominant position in the regional insomnia market compared to Spain's relatively smaller patient population.
• According to DelveInsight's estimates, insomnia is more prevalent among females than males in the United States, with around 32,685 thousand cases reported in women compared to 25,932 thousand in men, highlighting a significant gender gap in its occurrence.
• In 2023, the age-wise distribution of diagnosed insomnia cases in Japan revealed the highest prevalence among individuals aged 65 and older, with about 2,221 thousand cases, while the lowest prevalence was observed in the 18-24 age group, with roughly 292 thousand cases.
• In 2023, the EU4 and the UK reported approximately 23,283 thousand diagnosed prevalent cases of insomnia, with around 9,903 thousand attributed to acute insomnia and 13,380 thousand to chronic insomnia.
• Key Insomnia Companies: Idorsia Pharmaceutical, Syneos Health, Mochida Pharmaceutical, Merck, Janssen Pharmaceutical, Taisho Pharmaceutical, and others
• Key Insomnia Therapies: QUVIVIQ (daridorexant), BELSOMRA (suvorexant), Seltorexant (JNJ-42847922), TS-142, and others
• DelveInsight's analysis indicates that across the 7MM, insomnia is more prevalent in females, representing 58% of cases, while males account for 42%.
• The Insomnia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Insomnia pipeline products will significantly revolutionize the Insomnia market dynamics.
Insomnia Overview
Insomnia is a common sleep disorder characterized by difficulty falling asleep, staying asleep, or waking up too early and being unable to return to sleep. It can be short-term (acute) or long-lasting (chronic), often leading to fatigue, irritability, poor concentration, and decreased productivity during the day. Causes include stress, anxiety, depression, poor sleep habits, certain medications, or underlying health conditions. Treatment options range from lifestyle changes and cognitive behavioral therapy for insomnia (CBT-I) to medications that help regulate sleep patterns. Managing insomnia effectively is essential for maintaining overall health and well-being.
Get a Free sample for the Insomnia Market Report:
https://www.delveinsight.com/report-store/insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Insomnia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Insomnia Epidemiology Segmentation:
The Insomnia market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Insomnia
• Prevalent Cases of Insomnia by severity
• Gender-specific Prevalence of Insomnia
• Diagnosed Cases of Episodic and Chronic Insomnia
Download the report to understand which factors are driving Insomnia epidemiology trends @ Insomnia Epidemiology Forecast
https://www.delveinsight.com/sample-request/insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Insomnia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Insomnia market or expected to get launched during the study period. The analysis covers Insomnia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Insomnia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Insomnia Therapies and Key Companies
• QUVIVIQ (daridorexant): Idorsia Pharmaceutical/ Syneos Health/ Mochida Pharmaceutical
• BELSOMRA (suvorexant): Merck
• Seltorexant (JNJ-42847922): Janssen Pharmaceutical
• TS-142: Taisho Pharmaceutical
Discover more about therapies set to grab major Insomnia market share @ Insomnia Treatment Market
https://www.delveinsight.com/sample-request/insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Insomnia Market Drivers
• Increasing Prevalence
• Personalization of therapies
Insomnia Market Barriers
• Issues with diagnosis and poor knowledge
• Use of off-label drugs
• High economic burden
Scope of the Insomnia Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Insomnia Companies: Idorsia Pharmaceutical, Syneos Health, Mochida Pharmaceutical, Merck, Janssen Pharmaceutical, Taisho Pharmaceutical, and others
• Key Insomnia Therapies: QUVIVIQ (daridorexant), BELSOMRA (suvorexant), Seltorexant (JNJ-42847922), TS-142, and others
• Insomnia Therapeutic Assessment: Insomnia current marketed and Insomnia emerging therapies
• Insomnia Market Dynamics: Insomnia market drivers and Insomnia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Insomnia Unmet Needs, KOL's views, Analyst's views, Insomnia Market Access and Reimbursement
To know more about Insomnia companies working in the treatment market, visit @ Insomnia Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Market to Expand Significantly by 2034, States DelveInsight Report here
News-ID: 4245673 • Views: …
More Releases from DelveInsight Business Research
Stuttering Market Positioned for Accelerated Development Through 2034, DelveInsi …
The Stuttering market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Stuttering pipeline products will significantly revolutionize the Stuttering market dynamics.
DelveInsight's "Stuttering Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Stuttering, historical and forecasted epidemiology as well as the Stuttering market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Acute Ischemic Stroke Pipeline 2025: Therapies, MOA Insights, and Key Clinical T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Ischemic Stroke pipeline constitutes 20+ key companies continuously working towards developing 25+ Acute Ischemic Stroke treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Acute Ischemic Stroke Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.…
Global Clinical Trial Support Services Market to reach USD 43,160.56 million by …
According to DelveInsight's analysis, The clinical trial support services market is witnessing significant growth, driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders. This rise has resulted in a surge in clinical trial activities, higher R&D investments, and greater focus on drug development. Moreover, expanding collaborations between pharmaceutical, biotechnology, and medical device companies are boosting the need for specialized services, including regulatory assistance, data…
Global Radial Artery Compression Devices Market to reach USD 450.97 million by 2 …
According to DelveInsight's analysis, The growth of the radial artery compression devices market is mainly fueled by the rising prevalence of cardiovascular diseases and the increasing occurrence of risk factors such as hypertension, diabetes, obesity, and sedentary lifestyles. These factors collectively drive the need for efficient post-procedural hemostasis solutions.
DelveInsight's "Radial Artery Compression Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
